Fanrong Liang Selected Research

Dysmenorrhea (Menstrual Pain)

1/2022	Brain Mechanism of Acupuncture Treatment of Chronic Pain: An Individual-Level Positron Emission Tomography Study.
1/2021	Immediate Analgesic Effect of Acupuncture in Patients With Primary Dysmenorrhea: A fMRI Study.
1/2020	Resting-State Functional Connectivity Patterns Predict Acupuncture Treatment Response in Primary Dysmenorrhea.
7/2018	Acupoint herbal plaster for patients with primary dysmenorrhea: study protocol for a randomized controlled trial.
1/2017	Moxibustion for pain relief in patients with primary dysmenorrhea: A randomized controlled trial.
8/2015	[Characteristics of acupoints selection of moxibustion for primary dysmenorrhea based on data mining technology].
1/2015	Use of moxibustion to treat primary dysmenorrhea at two interventional times: study protocol for a randomized controlled trial.
1/2015	Application of acupoints and meridians for the treatment of primary dysmenorrhea: a data mining-based literature study.
1/2014	Effectiveness study of moxibustion on pain relief in primary dysmenorrhea: study protocol of a randomized controlled trial.
4/2013	Effectiveness of additional self-care acupressure for women with menstrual pain compared to usual care alone: using stakeholder engagement to design a pragmatic randomized trial and study protocol.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Fanrong Liang Research Topics

Disease

23	Pain (Aches) 01/2022 - 06/2009
18	Migraine Disorders (Migraine) 12/2022 - 10/2008
10	Dysmenorrhea (Menstrual Pain) 01/2022 - 04/2013
7	Dyspepsia (Indigestion) 03/2022 - 02/2010
6	Myocardial Ischemia (Ischemic Heart Diseases) 10/2022 - 01/2014
5	Stable Angina 01/2022 - 01/2014
4	Headache (Headaches) 12/2022 - 01/2020
4	Knee Osteoarthritis 06/2022 - 01/2019
3	Neoplasms (Cancer) 11/2021 - 01/2020
3	Migraine without Aura (Common Migraine) 01/2020 - 02/2016
3	Hypertension (High Blood Pressure) 01/2019 - 01/2016
2	Angina Pectoris 10/2022 - 12/2012
2	Reperfusion Injury 10/2022 - 01/2021
2	Chronic Pain 01/2022 - 01/2019
2	Stress Urinary Incontinence 11/2020 - 07/2020
2	Obesity 05/2015 - 01/2015
1	Fibrosis (Cirrhosis) 05/2022
1	Breast Neoplasms (Breast Cancer) 01/2022
1	Arthralgia (Joint Pain) 01/2022
1	Cancer Pain 01/2022
1	Essential Hypertension 01/2022
1	Dyspnea (Shortness of Breath) 11/2021
1	Inflammation (Inflammations) 01/2021
1	Nervous System Diseases (Neurological Disorders) 01/2021
1	Myasthenia Gravis 04/2020
1	Gout 04/2020
1	Osteoporosis 02/2020
1	Neurogenic Urinary Bladder (Bladder, Neurogenic) 01/2020
1	Xerostomia 01/2020
1	Postcholecystectomy Syndrome (Sump Syndrome) 01/2020
1	Rectal Neoplasms (Rectal Cancer) 01/2020
1	Spinal Cord Injuries (Spinal Cord Injury) 01/2020
1	Tinnitus 01/2020
1	Hemifacial Spasm 12/2019
1	Hiccup (Hiccups) 11/2019
1	Soft Tissue Injuries (Soft Tissue Injury) 07/2018
1	Stroke (Strokes) 10/2017
1	Cardiovascular Diseases (Cardiovascular Disease) 06/2016
1	Hemorrhage 01/2016
1	Polycystic Ovary Syndrome (Syndrome, Stein-Leventhal) 01/2016
1	Weight Gain 05/2015
1	Overweight 01/2015
1	Weight Loss (Weight Reduction) 01/2015
1	Vascular Dementia (Subcortical Arteriosclerotic Encephalopathy) 01/2015
1	Low Back Pain (Lumbago) 10/2014
1	Paralysis (Palsy) 01/2014
1	Epilepsy (Aura) 01/2014

Drug/Important Bio-Agent (IBA)

15	salicylhydroxamic acid (SHAM)IBA 12/2022 - 06/2009
6	Biomarkers (Surrogate Marker)IBA 01/2022 - 01/2013
5	Analgesics (Analgesic Drugs)IBA 12/2022 - 10/2013
5	Therapeutic UsesIBA 01/2020 - 03/2006
4	Pharmaceutical PreparationsIBA 04/2020 - 01/2015
3	PC6 extract (PC6)IBA 10/2022 - 01/2017
3	3- (3,5- dichlorophenyl)- 1- methyl- 2,5- pyrrolidinedione (DPMS)IBA 01/2021 - 02/2016
3	Nitroglycerin (Dynamite)FDA LinkGeneric 01/2018 - 01/2014
2	Isoproterenol (Isoprenaline)FDA LinkGeneric 05/2022 - 12/2015
2	Non-Steroidal Anti-Inflammatory Agents (NSAIDs)IBA 05/2020 - 04/2020
2	Celecoxib (Celebrex)FDA Link 05/2020 - 01/2019
1	Neurotransmitter Receptors (Neurotransmitter Receptor)IBA 10/2022
1	Long Noncoding RNAIBA 05/2022
1	Aromatase InhibitorsIBA 01/2022
1	Opioid Analgesics (Opioids)IBA 01/2022
1	Carbamazepine (Tegretol)FDA LinkGeneric 01/2022
1	theasinensin AIBA 01/2022
1	Antihypertensive Agents (Antihypertensives)IBA 01/2022
1	IronIBA 01/2021
1	Interleukin-1 Receptors (Interleukin 1 Receptor)IBA 04/2020
1	Hormones (Hormone)IBA 04/2020
1	Cyclooxygenase 2 Inhibitors (COX-2 Inhibitors)IBA 04/2020
1	Colchicine FDA LinkGeneric 04/2020
1	SDMIBA 01/2020
1	Dinoprostone (PGE2)FDA Link 01/2017
1	Purinergic P1 Receptors (Adenosine Receptor)IBA 06/2016
1	Purinergic Receptors (Receptors, Purine)IBA 06/2016
1	HydrogenIBA 01/2016
1	Clomiphene (Clomifene)FDA LinkGeneric 01/2016
1	Catechol O-Methyltransferase (Methyltransferase, Catechol)IBA 05/2015
1	Histones (Histone)IBA 01/2014
1	DNA (Deoxyribonucleic Acid)IBA 01/2014
1	Glutamic Acid (Glutamate)FDA Link 01/2014
1	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2014
1	LipidsIBA 01/2014
1	oxidized low density lipoproteinIBA 01/2014

Therapy/Procedure

22	Acupuncture Therapy 01/2022 - 03/2006
17	Acupuncture Points (Acupuncture Point) 06/2022 - 10/2008
13	Therapeutics 01/2022 - 02/2010
9	Moxibustion 02/2020 - 03/2006
7	Electroacupuncture 10/2022 - 01/2014
4	Aftercare (After-Treatment) 01/2022 - 06/2009
3	Complementary Therapies (Alternative Medicine) 01/2021 - 01/2015
2	Ligation 10/2022 - 11/2017
2	Acupressure (Shiatsu) 01/2022 - 04/2013
2	Meridians (Jing Luo) 11/2017 - 01/2015
1	Precision Medicine 03/2022
1	Acupuncture Analgesia 01/2021
1	Drug Therapy (Chemotherapy) 04/2020
1	Catgut 01/2015
1	Analgesia 01/2015
1	Massage (Zone Therapy) 10/2014
1	Punctures 10/2013